Promoter CpG island methylation in ion transport mechanisms and associated dietary intakes jointly influence the risk of clear-cell renal cell cancer
Author(s) -
Ivette A.G. Deckers,
Ma van Engeland,
Piet A. van den Brandt,
Leander Van Neste,
Patricia M.M.B. Soetekouw,
Maureen J.B. Aarts,
Marcella Baldewijns,
András Keszei,
Leo J. Schouten
Publication year - 2016
Publication title -
international journal of epidemiology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 3.406
H-Index - 208
eISSN - 1464-3685
pISSN - 0300-5771
DOI - 10.1093/ije/dyw266
Subject(s) - methylation , dna methylation , cpg site , hazard ratio , medicine , cancer , confidence interval , endocrinology , biology , oncology , cancer research , gene , genetics , gene expression
Sodium intake, but not potassium or fluid intake, has been associated with higher renal cell cancer (RCC) risk. However, risk factors may differ by molecular subtypes of the tumour. In renal physiology, electrolyte and water homeostasis is facilitated by ion transport mechanisms (ITM). Aberrant regulation of ITM genes, for example by promoter CpG island methylation, may modify associations between sodium, potassium and fluid intake and RCC risk.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom